Skip to main content
. 2020 Oct 23;10:543646. doi: 10.3389/fonc.2020.543646

Figure 3.

Figure 3

Kaplan–Meier curves of overall survival in 502 de novo metastatic nasopharyngeal carcinoma (NPC) patients accepting ≤4 cycles palliative chemotherapy (PCT) and accepting >4 cycles of PCT (A), Landmark analyses of overall survival for survivors of ≥1 year (B) and ≥3 years (C).